Boule Diagnostics AB Stock

Equities

BOUL

SE0011231158

Advanced Medical Equipment & Technology

Delayed Nasdaq Stockholm 07:03:43 2024-04-26 am EDT 5-day change 1st Jan Change
9.84 SEK +4.46% Intraday chart for Boule Diagnostics AB -0.20% -12.30%
Sales 2024 * 580M 53.27M Sales 2025 * 620M 56.98M Capitalization 366M 33.61M
Net income 2024 * 28M 2.57M Net income 2025 * 41M 3.77M EV / Sales 2024 * 0.77 x
Net Debt 2024 * 77.93M 7.16M Net Debt 2025 * 75.63M 6.95M EV / Sales 2025 * 0.71 x
P/E ratio 2024 *
12.7 x
P/E ratio 2025 *
8.74 x
Employees 228
Yield 2024 *
2.18%
Yield 2025 *
3.61%
Free-Float 61.67%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.46%
1 week-4.66%
Current month-5.14%
1 month-5.33%
3 months-13.89%
6 months-0.21%
Current year-16.04%
More quotes
1 week
9.28
Extreme 9.28
9.90
1 month
9.14
Extreme 9.14
9.96
Current year
9.05
Extreme 9.05
12.62
1 year
8.66
Extreme 8.66
12.78
3 years
8.66
Extreme 8.66
69.00
5 years
8.66
Extreme 8.66
79.60
10 years
8.66
Extreme 8.66
108.88
More quotes
Managers TitleAgeSince
Director of Finance/CFO - Dec. 31
Human Resources Officer - 22-09-30
Corporate Officer/Principal - 11-12-31
Members of the board TitleAgeSince
Chairman 71 20-12-31
Chairman 72 20-12-31
Director/Board Member 57 13-12-31
More insiders
Date Price Change Volume
24-04-26 9.84 +4.46% 6 675
24-04-25 9.42 -1.46% 19,433
24-04-24 9.56 -1.44% 1,521
24-04-23 9.7 +0.83% 2,928
24-04-22 9.62 -2.43% 14,206

Delayed Quote Nasdaq Stockholm, April 25, 2024 at 11:29 am EDT

More quotes
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
9.42 SEK
Average target price
10.4 SEK
Spread / Average Target
+10.40%
Consensus